چاپ صفحه |  صفحه نخست سامانه |  نویسندگان |  اطلاعات تفضیلی |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده ثبت کننده مقاله | رضا نقدی سده |
| مرحله جاری مقاله | تایید نهایی |
| دانشکده/مرکز مربوطه | روانپزشکی و علوم رفتاری |
| کد مقاله | 85043 |
| عنوان فارسی مقاله | روشهای مرحله بندی در بیماری آلزایمر |
| عنوان لاتین مقاله | Staging Methods in Alzheimer's Disease |
| نوع ارائه | سخنرانی |
| عنوان کنگره / همایش | 2nd international Healthy Aging Congress |
| نوع کنگره / همایش | بین المللی |
| کشور محل برگزاری کنگره/ همایش | Iran (Islamic Republic) |
| شهر محل برگزاری کنگره/ همایش | تبریز |
| سال انتشار/ ارائه شمسی | 1403 |
| سال انتشار/ارائه میلادی | 2024 |
| تاریخ شمسی شروع و خاتمه کنگره/همایش | 1403/02/25 الی 1403/02/26 |
| آدرس لینک مقاله/ همایش در شبکه اینترنت | https://healthyaging2024.ir/%da%86%da%a9%db%8c%d8%af%d9%87-%d8%b3%d8%ae%d9%86%d8%b1%d8%a7%d9%86%db%8c/ |
| آدرس علمی (Affiliation) نویسنده متقاضی | Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. |
| نویسنده | نفر چندم مقاله |
|---|---|
| رضا نقدی سده | اول |
| عنوان | متن |
|---|---|
| خلاصه مقاله | From the time German psychiatrist Alois Alzheimer introduced Alzheimer's Disease (AD) at the 37th Meeting of South-West German Psychiatrists in Tubingen on November 3, 1906, it was a clinicopathological concept(1, 2). But because pathological examination in viable patients was impossible, the typical multidomain amnestic type presentation of the disease was used as the sole way to diagnose AD without consideration of its pathological aspect. However, this method is neither sensitive nor specific for diagnosing AD(3-5). It wasn't until 2011 that a significant shift occurred in the diagnostic methods for Alzheimer's. Disease. Up until then, clinical diagnostic criteria were the only available method. However, the 2011 NIA-AA guidelines marked a turning point, introducing biomarkers as a new tool for diagnosing AD(6). In 2018, NIA-AA revised the 2011 guidelines and introduced a biomarker profile named ATN system and a new research framework for AD(7). In October 2023, the Alzheimer Association workgroup, led by Dr. Clifford in the Alzheimer's Research Center at Mayo Clinic in Rochester, Minnesota, unveiled a draft of the proposed criteria for diagnosing and staging AD(8). They proposed a new biological staging by amyloid and tau PET and an Integrated biological and clinical staging, a potential game-changer in our understanding of ongoing pathologies in demented patients. This could pave the way for more accurate and early diagnosis, offering hope for better management and treatment of Alzheimer's Disease(8). Key Words: Alzheimer's Disease, Diagnostic Criteria, Biological Staging, Integrated Staging, Alzheimer Association, National Institute on Aging |
| کلمات کلیدی |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| Certificate_9143327077.pdf | 1403/05/01 | 2580819 | دانلود |
| Abstract Book.pdf | 1403/05/01 | 9427611 | دانلود |
| Reza Naghdi Sadeh.pdf | 1403/05/01 | 381781 | دانلود |
